Table 4 Cognitive decline or change per 1 SD increase in baseline imaging biomarkers. Negative values indicate worse performance (decline), whereas positive values indicate better performance (less decline).

From: Structural and diffusion imaging in olfactory-related brain regions in Parkinson’s disease: predictors of clinical progression

Baseline Biomarker (↑1 SD)

Cognitive Outcome (years)

Change in Outcome per 1 SD

Approx. Raw Change

Amygdala MD (right)

HVLDR (0–4 yr)

–0.36 SD (decline)

≈ − 1.0 point (of 12)

Thalamus MD (right)

HVLTR (0–4 yr)

–0.42 SD (decline)

≈ − 2.2 points (of 36)

Insula MD (left)

SDM score (0–4 yr)

–0.40 SD (decline)

≈ − 3.9 points

OFC MD (lat. OFC, right)

LNS score (0–4 yr)

–0.34 SD (decline)

≈ − 0.9 points

Amygdala Volume (right)

HVLDR (0–2 yr)

+ 0.26 SD (less decline)

≈ +0.7 points (of 12)

Entorhinal Thickness (right)

HVLTR (2–4 yr)

+ 0.35 SD (less decline)

≈ +1.9 points (of 36)

OFC Cortical Thickness (left lat. OFC)

Semantic Fluency (0–2 yr)

+ 0.40 SD (improvement)

≈ +4.5 words

  1. SD: standard deviation, MD: Mean diffusivity, OFC: Orbitofrontal cortex.